Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inventrust Pptys Corp (NY: IVT )

30.75 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Inventrust Pptys Corp

Navigating 4 Analyst Ratings For InvenTrust Properties
Ratings for InvenTrust Properties (NYSE:IVT) were provided by 4 analysts in the past three months, showcasing a mix of bullish and ... 
Via Benzinga
Top 4 Real Estate Stocks That May Fall Off A Cliff This Quarter
Via Benzinga
IVT Stock Earnings: InvenTrust Properties Reported Results for Q1 2024
InvenTrust Properties just reported results for the first quarter of 2024. 
Via InvestorPlace
Q4 Retail REIT Earnings Vs. The New Retail Sales Report: Which One Should Investors Believe?
Via Benzinga
Looking for a Bargain? 7 Retirement Stocks to Buy That Are Down 10% in 2023
These seven top bargain retirement stocks dipped but show big promise for those heading to -- or are already in -- retirement. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
Via Benzinga
Earnings Scheduled For February 13, 2024
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million. 
Via Benzinga
InvenTrust Properties's Ex-Dividend Date Is Wednesday, Here's What You Need To Know
Via Benzinga
Earnings Scheduled For July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million. 
Via Benzinga
Wednesday Is Your Last Chance To Buy InvenTrust Properties Before The Dividend Payout
Via Benzinga
Earnings Scheduled For February 14, 2023
Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion. 
Via Benzinga
InvenTrust Properties's Ex-Dividend Date Is Wednesday, Here's What You Need To Know
Via Benzinga
3 REITS With The Highest Total Return Over The Past 3 Years
With the proverbial “blood in the streets” in the second half of 2022, many investors have decided the time may be right to buy some real estate investment trust (REIT) stocks for long-term... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
Upgrades 
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Drops Over 2%; Bottomline Technologies Shares Spike Higher
Toward the end of trading Friday, the Dow traded down 0.87% to 35,585.26 while the NASDAQ rose 0.43% to 15,245.07. The S&P also fell, dropping 0.32% to 4,653.92. The U.S. has... 
Via Benzinga
Earnings Scheduled For August 1, 2022
Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter. 
Via Benzinga
Earnings Scheduled For February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million. 
Via Benzinga
Earnings Scheduled For May 2, 2022
Companies Reporting Before The Bell • New Gold (AMEX:NGD) is estimated to report quarterly earnings at $0.03 per share on revenue of $212.42 million. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 22, 2022
Upgrades 
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; Darden Restaurants Posts Upbeat Earnings
Following the market opening Friday, the Dow traded down 1.33% to 35,420.19 while the NASDAQ fell 0.61% to 15,082.68. The S&P also fell, dropping 1% to 4,622.16. The U.S. has... 
Via Benzinga
50 Biggest Movers From Yesterday
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating... 
Via Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target... 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.